dc.creatorSANCHES JR., Jose Antonio
dc.creatorBRANDT, Hebert Roberto Clivati
dc.creatorMOURE, Emanuella Rosyane Duarte
dc.creatorPEREIRA, Guilherme Luiz Stelko
dc.creatorCRIADO, Paulo Ricardo
dc.date.accessioned2012-10-19T18:23:44Z
dc.date.accessioned2018-07-04T15:11:16Z
dc.date.available2012-10-19T18:23:44Z
dc.date.available2018-07-04T15:11:16Z
dc.date.created2012-10-19T18:23:44Z
dc.date.issued2010
dc.identifierANAIS BRASILEIROS DE DERMATOLOGIA, v.85, n.4, p.425-434, 2010
dc.identifier0365-0596
dc.identifierhttp://producao.usp.br/handle/BDPI/23011
dc.identifierhttp://apps.isiknowledge.com/InboundService.do?Func=Frame&product=WOS&action=retrieve&SrcApp=EndNote&UT=000282877200007&Init=Yes&SrcAuth=ResearchSoft&mode=FullRecord
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1619742
dc.description.abstractThe local and systemic treatment of tumors can cause changes in the skin, mucous membranes, hair and nails. Accurate diagnosis and appropriate treatment of side effects require knowledge about the patterns of the most common adverse reactions to drugs the patient may be using. The dermatologist must be familiar with the manifestations of certain soft tissue neoplasms, as well as with the adverse mucocutaneous forms of cancer treatment.
dc.languageeng
dc.publisherSOC BRASILEIRA DERMATOLOGIA
dc.relationAnais Brasileiros de Dermatologia
dc.rightsCopyright SOC BRASILEIRA DERMATOLOGIA
dc.rightsclosedAccess
dc.subjectChemotherapy, adjuvant
dc.subjectDrug therapy
dc.subjectDrug therapy, combination
dc.subjectSkin
dc.subjectSkin abnormalities
dc.subjectSkin pigmentation
dc.titleAdverse mucocutaneous reactions to chemotherapeutic agents - Part I
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución